Cardiome Pharma Corp. (NASDAQ: CRME) disclosed on Friday that its Chairman and CEO, Bob Rieder, was recently subject to involuntary ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE